Correlation Between Southwest Airlines and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Southwest Airlines and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Southwest Airlines and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Southwest Airlines and Carmell Therapeutics, you can compare the effects of market volatilities on Southwest Airlines and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Southwest Airlines with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Southwest Airlines and Carmell Therapeutics.
Diversification Opportunities for Southwest Airlines and Carmell Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Southwest and Carmell is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Southwest Airlines and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Southwest Airlines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Southwest Airlines are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Southwest Airlines i.e., Southwest Airlines and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Southwest Airlines and Carmell Therapeutics
Considering the 90-day investment horizon Southwest Airlines is expected to generate 0.23 times more return on investment than Carmell Therapeutics. However, Southwest Airlines is 4.33 times less risky than Carmell Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.05 per unit of risk. If you would invest 3,600 in Southwest Airlines on September 12, 2024 and sell it today you would lose (256.00) from holding Southwest Airlines or give up 7.11% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Southwest Airlines vs. Carmell Therapeutics
Performance |
| Timeline |
| Southwest Airlines |
| Carmell Therapeutics |
Southwest Airlines and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Southwest Airlines and Carmell Therapeutics
The main advantage of trading using opposite Southwest Airlines and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Southwest Airlines position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Southwest Airlines vs. United Airlines Holdings | Southwest Airlines vs. American Airlines Group | Southwest Airlines vs. JetBlue Airways Corp | Southwest Airlines vs. Delta Air Lines |
| Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Virax Biolabs Group | Carmell Therapeutics vs. Neurobo Pharmaceuticals | Carmell Therapeutics vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| CEOs Directory Screen CEOs from public companies around the world |